Cargando…

The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction

Background: Inflammatory bowel disease (IBD) is a chronic and complex disease that requires a multidisciplinary team, including clinical pharmacists, to improve the quality of care and patient outcome. This present study aimed to assess the satisfaction of patients with IBD and physicians regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Alrashed, Fatema, Almutairi, Najlaa, Shehab, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602087/
https://www.ncbi.nlm.nih.gov/pubmed/36292267
http://dx.doi.org/10.3390/healthcare10101818
_version_ 1784817226292920320
author Alrashed, Fatema
Almutairi, Najlaa
Shehab, Mohammad
author_facet Alrashed, Fatema
Almutairi, Najlaa
Shehab, Mohammad
author_sort Alrashed, Fatema
collection PubMed
description Background: Inflammatory bowel disease (IBD) is a chronic and complex disease that requires a multidisciplinary team, including clinical pharmacists, to improve the quality of care and patient outcome. This present study aimed to assess the satisfaction of patients with IBD and physicians regarding clinical pharmacist interventions in outpatient and inpatient settings. Methods: A survey-based study was performed between 1 March and 1 August 2022 in a tertiary care IBD center. Two different questionnaires were distributed among patients and physicians focusing on satisfaction with the clinical pharmacist services. Patient demographics were obtained. Descriptive statistics were used to summarize the results of the survey. Results: A total of 108 patients with IBD and 23 physicians participated in this study. Among study participants, Crohn’s disease (CD) accounted for 64.8% of the total participants, while 35.2% of patients had ulcerative colitis (UC). Regarding the patient survey, most patients were extremely satisfied with clinical pharmacists’ services, during which the majority strongly agreed or agreed that they were satisfied with the counseling session. However, five patients were unsure about the amount of time spent with the clinical pharmacist. There were no patients dissatisfied with any of the services. Finally, two physicians were not sure regarding clinical pharmacists monitoring patients’ responses in of terms of toxicity and adverse effects. Conclusions: the current study illustrates patients’ and physicians’ high satisfaction with clinical pharmacists’ services in outpatient and inpatient settings. The findings of this study as well as previous studies necessitate expanding the clinical pharmacist services in the gastroenterology field.
format Online
Article
Text
id pubmed-9602087
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96020872022-10-27 The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction Alrashed, Fatema Almutairi, Najlaa Shehab, Mohammad Healthcare (Basel) Article Background: Inflammatory bowel disease (IBD) is a chronic and complex disease that requires a multidisciplinary team, including clinical pharmacists, to improve the quality of care and patient outcome. This present study aimed to assess the satisfaction of patients with IBD and physicians regarding clinical pharmacist interventions in outpatient and inpatient settings. Methods: A survey-based study was performed between 1 March and 1 August 2022 in a tertiary care IBD center. Two different questionnaires were distributed among patients and physicians focusing on satisfaction with the clinical pharmacist services. Patient demographics were obtained. Descriptive statistics were used to summarize the results of the survey. Results: A total of 108 patients with IBD and 23 physicians participated in this study. Among study participants, Crohn’s disease (CD) accounted for 64.8% of the total participants, while 35.2% of patients had ulcerative colitis (UC). Regarding the patient survey, most patients were extremely satisfied with clinical pharmacists’ services, during which the majority strongly agreed or agreed that they were satisfied with the counseling session. However, five patients were unsure about the amount of time spent with the clinical pharmacist. There were no patients dissatisfied with any of the services. Finally, two physicians were not sure regarding clinical pharmacists monitoring patients’ responses in of terms of toxicity and adverse effects. Conclusions: the current study illustrates patients’ and physicians’ high satisfaction with clinical pharmacists’ services in outpatient and inpatient settings. The findings of this study as well as previous studies necessitate expanding the clinical pharmacist services in the gastroenterology field. MDPI 2022-09-21 /pmc/articles/PMC9602087/ /pubmed/36292267 http://dx.doi.org/10.3390/healthcare10101818 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alrashed, Fatema
Almutairi, Najlaa
Shehab, Mohammad
The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction
title The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction
title_full The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction
title_fullStr The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction
title_full_unstemmed The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction
title_short The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction
title_sort role of clinical pharmacists in improving quality of care in patients with inflammatory bowel disease: an evaluation of patients’ and physicians’ satisfaction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602087/
https://www.ncbi.nlm.nih.gov/pubmed/36292267
http://dx.doi.org/10.3390/healthcare10101818
work_keys_str_mv AT alrashedfatema theroleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction
AT almutairinajlaa theroleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction
AT shehabmohammad theroleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction
AT alrashedfatema roleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction
AT almutairinajlaa roleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction
AT shehabmohammad roleofclinicalpharmacistsinimprovingqualityofcareinpatientswithinflammatoryboweldiseaseanevaluationofpatientsandphysicianssatisfaction